Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New treatments, and better use of existing treatments, are essential to reduce ...

Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...

Journal of Nuclear Medicine February 2025, jnumed.124.267855; DOI: https://doi.org/10.2967/jnumed.124.267855 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Journal of Nuclear Medicine February 2025, jnumed.124.269401; DOI: https://doi.org/10.2967/jnumed.124.269401 ...

Radiopharmaceutical therapy (RPT), with its targeted delivery of cytotoxic ionizing radiation, demonstrates significant potential for treating a wide spectrum of malignancies, with particularly unique ...

Journal of Nuclear Medicine February 2025, jnumed.124.267809; DOI: https://doi.org/10.2967/jnumed.124.267809 ...

Journal of Nuclear Medicine February 2025, jnumed.124.268719; DOI: https://doi.org/10.2967/jnumed.124.268719 ...

Journal of Nuclear Medicine February 2025, jnumed.124.268340; DOI: https://doi.org/10.2967/jnumed.124.268340 ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Between June 2013 and April 2018, datasets from 7,013 patients with PSMA PET for PCa were retrospectively reviewed at 6 high-volume nuclear medicine centers, and 16 patients with PSA persistence after ...

Journal of Nuclear Medicine January 2025, jnumed.124.268578; DOI: https://doi.org/10.2967/jnumed.124.268578 ...